Results 141 to 150 of about 3,454 (161)
Mucolytics for Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Meta-Analysis.
European Respiratory Review, 2023 This meta-analysis explored the safety and effectiveness of mucolytics as an add-on treatment for chronic obstructive pulmonary disease (COPD) exacerbations.
Stavros Tryfon +2 more
exaly +2 more sources
Use of Mucolytics in COPD: A Delphi Consensus Study [PDF]
Respiratory Medicine, 2020 Background: International guidelines recommend mucolytic agents as add-on therapy in selected patients with COPD because they may reduce exacerbations and improve health status.
Paola Rogliani, Vladimír Koblížek
exaly +3 more sources
Respiratory Medicine, 2008 BACKGROUND: Antibiotics, antitussives and mucolytics are commonly used in asthma, despite limited evidence for their effectiveness. The correlates of use for these medication classes in asthma were identified. METHODS: Asthma patients aged 18-50 who were
Eric Van Ganse +2 more
exaly +2 more sources
Thiol-Based Drugs in Pulmonary Medicine: Much More Than Mucolytics [PDF]
Trends in Pharmacological Sciences, 2019 Thiol-based drugs are considered as mucolytics because they decrease the viscosity and mostly decrease the elasticity of bronchial secretions by reducing disulfide bonds in proteins.
Paola Rogliani +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Literature-Based Comparative Study Between Herbal and Synthetic Mucolytics
Current Respiratory Medicine Reviews, 2023Tapash Chakraborty
exaly
Activity of Some Mucolytics Against Bacterial Adherence to Mammalian Cells
Applied Biochemistry and Biotechnology, 2009Mahmoud Yassien +2 more
exaly
Mucolytics for COPD: Negotiating a Slippery Slope Towards Proof of Efficacy.
European Respiratory Journal, 2017Shawn D. Aaron
exaly